Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
7.17
-0.03 (-0.42%)
At close: Aug 24, 2026, 4:00 PM EDT
7.15
-0.02 (-0.28%)
After-hours: Aug 24, 2026, 7:48 PM EDT
Precigen Market Cap
Precigen has a market cap or net worth of $2.57 billion as of August 24, 2026. Its market cap has increased by 106.11% in one year.
Market Cap
2.57B
Enterprise Value
2.63B
1-Year Change
106.11%
Ranking
Category
Stock Price
$7.17
ChartMarket Cap Chart
Since August 8, 2013, Precigen's market cap has increased from $2.32B to $2.57B, an increase of 10.64%. That is a compound annual growth rate of 0.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 2.57B | 73.57% |
| Dec 31, 2025 | 1.48B | 350.91% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
| Aug 8, 2013 | 2.32B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.77B |
| Viridian Therapeutics | 2.75B |
| AtaiBeckley | 2.74B |
| Trevi Therapeutics | 2.56B |
| Pharvaris | 2.55B |
| Ultragenyx Pharmaceutical | 2.54B |
| Nektar Therapeutics | 2.53B |
| Ocular Therapeutix | 2.43B |